← Leaderboards
Jianmin Zhang
Roswell Park Cancer Institute Corp
$3,685,953
Attributed
$4,601,307
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,601,307 · 5
By mechanism
R01$3,821,107 · 3
R21$615,325 · 1
R03$164,875 · 1
Top collaborators
- Scott I. Abrams2 shared
- Hai Wang1 shared
Most similar at Roswell Park Cancer Institute Corp
Same institution · by research overlap
- Li Tang$8,006,573
- Scott I. Abrams$11,133,748
- Hai Wang$350,345
Others in their field
Top investigators on “Malignant Breast Neoplasm”
- David Heimbrook · Leidos Biomedical Research, Inc.$347,312,063
- Norman Wolmark · Nsabp Foundation, Inc.$122,067,540
- Walter John Curran · Thomas Jefferson University$97,002,422
- Monica M Bertagnolli · Strang Cancer Prevention Center$84,975,759
- Joseph P. Costantino · University Of Pittsburgh At Pittsburgh$68,847,428
- Jan C Buckner · Mayo Clinic Coll Of Medicine, Rochester$60,763,376
Research focus
Malignant Breast NeoplasmMolecularNeoplasm MetastasisOverexpressionSignal PathwayTriple-Negative Invasive Breast CarcinomaTumorHigh RiskIncidenceGenesCessation Of LifeMediatingCancer Stem CellCellsTumor ProgressionMouse ModelTransgenic MiceRecurrenceBreast Cancer PatientBreast Cancer ProgressionPathway InteractionsBreast Cancer CellGenome-WideInnovation
Grant awards (14)
Decipher the Molecular Mechanisms of Breast Cancer Bone Metastasis$700,690
R01 · FY2025 · CA
Dissecting Molecular Mechanisms of Tumor-Induced Myeloid-Mediated Immune Suppression in Triple-Negative Breast Cancer$558,523
R01 · FY2025 · CA · contact PI
TAZ-driven Regulation of Tumor Microenvironment in Triple-Negative Breast Cancer$78,125
R03 · FY2025 · CA · contact PI
Dissecting Molecular Mechanisms of Tumor-Induced Myeloid-Mediated Immune Suppression in Triple-Negative Breast Cancer$571,496
R01 · FY2024 · CA · contact PI
TAZ-driven Regulation of Tumor Microenvironment in Triple-Negative Breast Cancer$49,202
R03 · FY2024 · CA · contact PI
TAZ-driven Regulation of Tumor Microenvironment in Triple-Negative Breast Cancer$37,548
R03 · FY2024 · CA · contact PI
The role of TAZ in breast cancer initiation and progression$397,005
R01 · FY2021 · CA · contact PI
The role of TAZ in breast cancer initiation and progression$397,031
R01 · FY2020 · CA · contact PI
The role of TAZ in breast cancer initiation and progression$385,157
R01 · FY2019 · CA · contact PI
The role of TAZ in breast cancer initiation and progression$405,084
R01 · FY2018 · CA · contact PI
The role of TAZ in breast cancer initiation and progression$406,121
R01 · FY2017 · CA · contact PI
Hippo signaling pathway in breast cancer disparities: a translational approach$229,028
R21 · FY2015 · CA · contact PI
Hippo signaling pathway in breast cancer disparities: a translational approach$195,441
R21 · FY2015 · CA · contact PI
Hippo signaling pathway in breast cancer disparities: a translational approach$190,856
R21 · FY2014 · CA · contact PI